secwatch.observer — SEC 8-K summary
======================================

Issuer:     COMPASS Pathways plc (CMPS)
CIK:        0001816590
Form:       8-K
Filed at:   2026-08-05T10:31:09+00:00
Accession:  0001816590-26-000059
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Compass Pathways reports Q2 2026 net loss of $253.8M; COMP360 NDA on track for Q4
--------------------------------------------------------------------------------

- Q2 net loss $253.8M ($1.88/share) vs $38.4M in Q2 2025; increase from non-cash warrant adjustments.
- Cash and equivalents $433.3M as of June 30, 2026, up from $149.6M at Dec 31, 2025; expected to fund operations into 2028.
- Rolling NDA submission for COMP360 in TRD underway; final submission expected Q4 2026; commercial launch targeted H1 2027.
- Positive Phase 3 data showed rapid onset and durable benefit through 6 months; COMP360 expected to be blockbuster if approved.
- R&D expenses $29.2M in Q2 2026 vs $30.3M in Q2 2025; G&A increased to $23.2M from $12.6M due to commercial prep.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816590/000181659026000059/0001816590-26-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816590/000181659026000059/cmps-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001816590-26-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer